CAR T-cell research is moving rapidly from bench to bedside. This Experimental Hematology & Oncology series welcomes studies covering the latest development in CAR T-cell therapy. Submissions can be made via the journal's submission system.
For more information, visit the full collection page.
This Experimental Hematology & Oncology and Journal of Hematology & Oncology series intends to publish Correspondences with latest updates on novel agents and regimens from major conferences on blood and cancer disorders. Each Correspondence serves as a summary and analysis of 5 or more abstracts on a similar focus from a major international conference. Submissions can be made via the journal's submission system. For more information, visit the full collection page.
In recognition of Blood Cancer Awareness Month, this September, Editors from across our hybrid and OA oncology journals have chosen a compilation of articles to highlight the latest advances in blood cancer research.
Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.
Delong Liu, New York Medical College
Kongming Wu, Tongji Medical College
"Like our companion journal, Journal of Hematology & Oncology, Experimental Hematology & Oncology publishes on all aspects of hematology and oncology, which are closely intertwined and rapidly evolving fields. It also emphasizes basic and translational research, as well as patient-oriented research and clinical trials with ‘negative’ or preliminary results. The journal is an international platform for sharing findings in these areas and adheres to fast turnaround times."
2022 Citation Impact
10.9 - 2-year Impact Factor
7.2 - 5-year Impact Factor
1.609 - SNIP (Source Normalized Impact per Paper)
1.908 - SJR (SCImago Journal Rank)
2022 Speed
2 days submission to first editorial decision for all manuscripts (Median)
79 days submission to accept (Median)
2022 Usage
527,307 downloads
840 Altmetric mentions
06 April 2023
